Effekten var den samme i undergruppen af patienter, der var eksponeret for tidligere systemiske behandlinger sammenlignet med den totale undersøgelsespopulation.
Efficacy was similar in the subgroup of patients that were exposed to previous systemic therapies compared to the overall study population.